AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|
10.4 C
New York
Thursday, October 22, 2026

Tag: disease

/C O R R E C T I O N – Vivalink/

In the news release, Vivalink Powers Translational Medicine Through Continuous Physiologic Monitoring Across Healthcare and Clinical Research, issued Oct. 22, 2026 by Vivalink over...

Integrating Spatial Transcriptomics and Proteomics: Unlocking More from Every Tissue Section, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how spatial proteomics and spatial transcriptomics can be integrated into the same tissue section to provide a more complete...

Tikva Allocell Selected to Present Preclinical CD19.SB9.CAR-EBVST Data at ACR Convergence 2026

Oral presentation will feature preclinical research evaluating Tikva's armored allogeneic CD19 CAR T-cell therapy as a potential lymphodepletion-free approach for systemic lupus erythematosusSINGAPORE, Oct....

Ping An Unveils China’s First Brain Health Service Management Program, Focused on Alzheimer’s Prevention and Care

HONG KONG and SHANGHAI, Oct. 22, 2026 /PRNewswire/ -- On 21 October, Ping An Insurance (Group) Company of China ("Ping An") unveiled China's first...

“All Access Hosted by Andy Garcia” Explores How Nanomix Group Unlocks the Potential of Silicon

The upcoming segment explores the second most abundant element on earth and why its bioavailable form is critical to living organisms across agriculture, animal...

Smarter Cars, Robots and Disease Prevention: WSTDF Examines How Future Industries Take Shape

CHONGQING, China, Oct. 22, 2026 /PRNewswire/ -- A news report from iChongqing. ...

Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™

Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S.FDA clearance of multiFiltratePRO and approval of dedicated...

Rapid Infection Diagnostics Appoints Mario Savarese to Strategic Advisory Board

CALGARY, AB, Oct. 21, 2026 /PRNewswire/ -- Rapid Infection Diagnostics Inc. (RID), a Canadian life sciences company specializing in the use of metabolomics for...

Rapid Infection Diagnostics Appoints Mario Savarese to Strategic Advisory Board

CALGARY, AB, Oct. 21, 2026 /CNW/ -- Rapid Infection Diagnostics Inc. (RID), a Canadian life sciences company specializing in the use of metabolomics for...

Protect Yourself and Your Community: Accordia Health Encourages the Public to Get Annual Flu Vaccine

MOBILE, Ala., Oct. 21, 2026 /PRNewswire/ -- As flu season gets underway, Accordia Health encourages everyone eligible to get the annual flu vaccine. Influenza,...

Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids

DUBLIN, Oct. 22, 2026 /PRNewswire/ -- Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced...

Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids

DUBLIN, Oct. 21, 2026 /CNW/ -- Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced...

Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids

DUBLIN, Oct. 21, 2026 /PRNewswire/ -- Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced...

Kibow Therapeutics to Present Phase 2b Results for KT-301 in Stage 4 Chronic Kidney Disease at ASN Kidney Week 2026

Randomized, Double-Blind Phase 2b Data in 327 Patients, Plus New Mechanistic Research, to Be Presented October 23 in DenverEXTON, Pa., Oct. 21, 2026 /PRNewswire/...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDisease